Liquid Biopsy and Precision Medicine Transform Colorectal Cancer Care for Younger Patients
Colorectal cancer diagnoses in people under 50 now account for nearly half of all new cases, prompting specialized treatment programs that use precision medicine and liquid biopsy technology to customize care based on individual tumor genetics.